GPC1 and familial pancreatic carcinoma: One approach combined differential centrifugation enrichment followed by flow-cytometry [122], while a fluorescence in situ hybridization (FISH) approach detected GPC1 mRNA directly from the serum of patients with pancreatic cancer without the need for exosome purification and with potential as an accurate bio-chip platform [147].